RICHMOND — The Lingerfelt Cos. has started work on the third phase of BioTech 8, a six-story tower within downtown Richmond's 34-acre Virginia BioTechnology Research Park.
The project will complete a $100 million, three-building headquarters complex for Health Diagnostics Laboratory Inc., (HDL) one of the country's fastest growing health management companies.
The project totals 276,000 square feet, including a four-story, 485-space parking deck.
According to Ryan Lingerfelt, a principal at Lingerfelt Cos., the third phase is scheduled for completion in spring 2014. “Since partnering with HDL in 2009, development has been fast paced,” says Lingerfelt. “HDL is a significant complement to our growing health care development portfolio.”
The Phase III BioTech 8 expansion will bring the total development at biotech park to more than 1.2 million square feet. The park currently has a mix of more than 60 public and private bioscience companies, including three publicly traded firms.
Lingerfelt recently completed several other local healthcare-related projects including OrthoVirginia, a $25 million, 70,000-square-foot facility in Chesterfield County for OrthoVirginia orthopedic specialists and HCA Virginia CJW Sports Medicine; the Virginia Community Healthcare Association headquarters, a two-story building; and the 100,000-square-foot Bon Secours Heart Institute.
— Liz Burlingame